Literature DB >> 8403804

Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.

M S Markell1, B T Altura, R L Barbour, B M Altura.   

Abstract

1. Ionized magnesium, measured using a newly developed ion-selective electrode, total magnesium, and ionized and total calcium were evaluated in 39 stable, long-term, cyclosporin-treated renal transplant recipients and compared with those of age-matched, non-transplanted control subjects. Total cholesterol, cyclosporin trough level, serum creatinine, time after-transplant and the ratio of ionized calcium to ionized magnesium were also measured in renal transplant recipients and the relationships between these variables and ionized and total magnesium were evaluated. 2. Renal transplant recipients exhibited marked deficits in ionized magnesium, with a mean value of 0.54 +/- 0.01 mmol/l as compared with 0.61 +/- 0.006 mmol/l for normal control subjects (P < or = 0.05), with a more moderate deficit in total magnesium. Values for ionized and total calcium did not differ. By stepwise linear multiple regression analysis, ionized magnesium was significantly related to cyclosporin trough level and total cholesterol but not to serum creatinine, time after transplant or the dose of cyclosporin. Ionized magnesium correlated inversely with cyclosporin trough level and directly with total cholesterol. The ratio of ionized calcium to ionized magnesium was elevated in renal transplant recipients when compared with control subjects and correlated positively with the cyclosporin trough level. 3. Deficits in ionized magnesium are common during the late post-transplant period in cyclosporin-treated renal transplant recipients. Ionized magnesium may be a more sensitive clinical parameter than total magnesium in this population, in whom total magnesium may be only mildly decreased in the setting of a severe deficit in ionized magnesium. 4. Ionized magnesium correlates with the cyclosporin level.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403804     DOI: 10.1042/cs0850315

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.

Authors:  Nilank C Shah; Gatha J Shah; Zhiqiang Li; Xian-Cheng Jiang; Bella T Altura; Burton M Altura
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  Myopathy with ragged red fibres following renal transplantation: possible role of cyclosporin-induced hypomagnesaemia.

Authors:  A J Larner; S G Sturman; J B Hawkins; M Anderson
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 4.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

5.  Two Cases of Liver Transplantation With a High Ionized Magnesium to Total Magnesium Ratio.

Authors:  Kunihide Okubo; Takao Kato; Yuki Shiko; Yohei Kawasaki; Ayako Inoda; Kaoru Koyama
Journal:  Cureus       Date:  2022-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.